Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease rheumatoid arthritis
Symptom C0021311|infections
Sentences 30
PubMedID- 26048170 Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the orencia and rheumatoid arthritis (ora) registry.
PubMedID- 22548187 To analyse the potential risk factors of nosocomial infections in patients with active rheumatoid arthritis (ra).
PubMedID- 21285116 Background: glucocorticoid therapy is strongly associated with an elevated risk of serious infections in patients with rheumatoid arthritis (ra).
PubMedID- 23238605 Urinary tract infections in patients with rheumatoid arthritis.
PubMedID- 26473742 We sought to determine if opioid use is associated with an increased risk of serious infections in patients with rheumatoid arthritis (ra).
PubMedID- 22791271 Risk factors of severe infections in patients with rheumatoid arthritis treated with leflunomide.
PubMedID- 25190189 Association between disease activity and risk of serious infections in subjects with rheumatoid arthritis treated with etanercept or disease-modifying anti-rheumatic drugs.
PubMedID- 24822058 Interestingly, the isolation of s. aureus from arthritis lesions increases to 80% in joint infections in patients with concurrent rheumatoid arthritis (ra) and in those with diabetes.
PubMedID- 20506353 Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry.
PubMedID- 22237765 Simultaneous quantitative analysis of the expression of cd64 and cd35 on neutrophils as markers to differentiate between bacterial and viral infections in patients with rheumatoid arthritis.
PubMedID- 25664400 Adverse events and infections in patients with rheumatoid arthritis treated with conventional drugs or biologic agents: a real world study.
PubMedID- 24962980 Reply to talarico et al.'s comment: "rate of serious infections in patients with rheumatoid arthritis receiving tumor necrosis factor (tnf)-alpha antagonist: a prospective observational study".
PubMedID- 21735355 Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab.
PubMedID- 20478071 It has been suggested that neutrophil cd64 expression can be used to aid in the diagnosis of infections in patients with rheumatoid arthritis .
PubMedID- 24384637 Risk of mycobacterial infections associated with rheumatoid arthritis in ontario, canada.
PubMedID- 22887849 Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the dutch rheumatoid arthritis monitoring (dream) registry.
PubMedID- 22833532 Objective: to assess risk and risk factors for serious infections in seniors with rheumatoid arthritis (ra) using a case-control study nested within an ra cohort.
PubMedID- 23192911 The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment.
PubMedID- 20675706 Anti-tnf therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the british society for rheumatology biologics register with special emphasis on risks in the elderly.
PubMedID- 21288960 Objective: to determine the relationship of disease activity to infections in patients with rheumatoid arthritis (ra).
PubMedID- 24498926 The objective of this study was to determine if anti-tnf therapy is associated with an increased occurrence of serious skin and soft tissue infections requiring hospitalization in patients with rheumatoid arthritis.
PubMedID- 25975452 We did a bayesian network meta-analysis of published trials using a binomial likelihood model to assess the risk of serious infections in patients with rheumatoid arthritis who were treated with biological drugs, compared with those treated with traditional dmards.
PubMedID- 19359261 Objective: to examine the association of methotrexate (mtx) and tumour necrosis factor (tnf) antagonists with the risk of infectious outcomes including opportunistic infections in patients with rheumatoid arthritis (ra).
PubMedID- 24414744 Serious infections in patients with rheumatoid arthritis and other immune-mediated connective tissue diseases exposed to anti-tnf or rituximab: data from the spanish registry biobadaser 2.0.
PubMedID- 22500176 Risk of orthopedic surgical site infections in patients with rheumatoid arthritis treated with antitumor necrosis factor alfa therapy.
PubMedID- 22536258 Complications related to biologicals are discussed in this paper entitled “risk of orthopedic site surgical infections in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alfa therapy.” the authors performed a literature review of infections associated to orthopedic surgery in rheumatoid arthritis patients treated with anti-tnf and found inconclusive data in this field.
PubMedID- 26318385 Objectives: to evaluate the risk of opportunistic infections (ois) in patients with rheumatoid arthritis (ra) treated with tofacitinib.
PubMedID- 24962976 Rate of serious infections in patients with rheumatoid arthritis receiving tumor necrosis factor (tnf)-alpha antagonist: a prospective observational study.
PubMedID- 23547208 Objective: to examine trends in the rates of serious infections among patients diagnosed with rheumatoid arthritis (ra) in 1995-2007 compared to rates previously reported from the same geographical area diagnosed 1955-1994.
PubMedID- 25926715 Three patients developed grade 3–4 neutropenia, and six developed severe infections.67 a cochrane analysis of anakinra in rheumatoid arthritis found that while serious infections were clinically higher than placebo, this was not statistically significant.68 a similar analysis has not been done for urticarial conditions.

Page: 1